—

Versant Venture Management, LLC

Q1 2026 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    8

  • Value ($000)

    $141,411

  • Date Filed
    05/05/2026
  • Form type
    13F-HR
  • CIK
    0001560009
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
G
GLUE

Monte Rosa Therapeutics, Inc.

COMMON STOCK
61225M102
$52.32M
37 %

3,180,780

I
IPSC

Century Therapeutics, Inc.

COMMON STOCK
15673T100
$27.5M
19 %

12,166,109

L
LENZ

Lenz Therapeutics, Inc.

COMMON STOCK
52635N103
$24.31M
17 %

2,656,888

---

Jade Biosciences, Inc.

COMMON STOCK
008064206
$21.44M
15 %

1,525,820

C
CTNM

Contineum Therapeutics, Inc.

COMMON STOCK
21217B100
$7.09M
5 %

542,628

---

CRISPR Therapeutics AG

COMMON SHARES
H17182108
$7.08M
5 %

148,831

S
SKYE

Skye Bioscience, Inc.

COMMON STOCK
83086J200
$1.23M
1 %

2,007,704

T
TPST

Tempest Therapeutics, Inc.

COMMON STOCK
87978U108
$442.43K
0 %

269,772

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 8 of 8